Innovations And Future Prospects in Copd Management: Advancing Treatment and Care

Chronic Obstructive Pulmonary Disease (COPD) remains a major cause of disease, death, and economic burden globally, particularly in low- and middle-income countries where access to new therapies remains limited. New strategies are being formulated to revolutionize the management of COPD as the global health landscape evolves. Treatment strategies are evolving due to advances in precision medicine, biologic therapies, and AI-based healthcare solutions. By targeting inflammation at the molecular level, biologic drugs such as Dupixent are creating new opportunities for individualized treatment. AI-based diagnostic devices and intelligent inhalers are some of the digital health technology that are improving patient compliance, disease monitoring, and early diagnosis. In addition, treatment efficacy and patient outcomes are being enhanced by regenerative medicine and next-generation drug delivery technologies such as sustained-release inhalers and nano-formulations. The future of COPD management will be defined by innovation, access, and targeted interventions as the world progresses toward a more technology-driven and globalized health environment. The paper discusses the most recent progress and looks to a future where managing COPD becomes more effective, equitable, and sustainable across the globe.